Emory University School of Medicine
Head and Neck Medical Oncology
Dr. Saba’s academic work focuses on aero-digestive malignancies, namely head and neck and esophageal cancer, as well as the clinical development of novel agents and therapeutic modalities. He is the principal investigator on several head and neck cancer trials including investigator initiated studies focusing on novel approaches for treating these diseases.
Dr. Saba’s work is funded by a Career Development Program grant through the Emory Head and Neck Cancer SPORE, and he is a co-investigator on the DOD, USAMRMC grant “Multi-Biomarker System Using Quantum Dot Technology for Assessments of Prognosis of Lung Cancer”. He has also received multiple pharmaceutically funded grants. Dr. Saba is working on correlating clinical outcomes with biomarkers in head and neck and esophageal cancer. He leads several clinical trials in head and neck and esophageal cancer and is a co-leader of project 4 of the Emory Head and Neck Cancer SPORE involving the application of nanotherapeutics-based therapy for treating advanced head and neck cancer. His goal is to continue collaborating with basic scientists to advance drug development and clinical trials for aero-digestive tumors.
Dr. Saba is a member of the ECOG head and neck cancer committee, and an elected member of the American Head and Neck Society (AHNS). Dr. Saba serves on the American College of Radiology appropriateness criteria panel for Head and Neck Cancer. He is the author of multiple peer-reviewed articles, editorials, review papers and book chapters. Dr. Saba serves on the editorial board of the American Journal of Clinical Oncology (AJCO), and has served as a reviewer for more than 14 journals.
Dr Saba’s research interest is primarily focused on translational research in upper aerodigestive tract malignancies through discovery of novel agents and novel approaches in treating esophageal and head and neck cancers. Through conducting investigator-initiated clinical trials in primary therapy and the metastatic or recurrent setting, and the conduct of research focusing on biomarker correlative studies, Dr. Saba’s main goal is to significantly impact clinical care and outcome of patients with upper aerodigestive tumors.
View Publications on Research Gate
View publications on PubMed